Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Headache
|
April 11, 2012
The development of a survey to measure completeness of response to migraine therapy
Cheryl D Coon, Sheri E Fehnel, Kimberly H Davis, et al.
Headache
|
February 1, 2008
Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines
Merle L Diamond, Roger K Cady, Lian Mao, et al.
Headache
|
October 13, 2009
Expanding access to triptans: assessment of clinical outcome
Roger K Cady, Jerome Goldstein, Stephen Silberstein, et al.
Headache
|
August 16, 2008
Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study
George Apostol, Roger K Cady, Genevieve A Laforet, et al.
Headache
|
November 3, 2010
Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database
Anthony J Rodgers, Carolyn M Hustad, Roger K Cady, et al.
Headache
|
May 6, 2015
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks
Stewart J Tepper, Roger K Cady, Stephen Silberstein, et al.
Headache
|
February 16, 2007
Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study)
Ninan T Mathew, Gary Finlayson, Timothy R Smith, et al.
Headache
|
October 31, 2014
A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study)
Roger K Cady, Peter J McAllister, Egilius L H Spierings, et al.
Headache
|
February 24, 2006
Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment
Dennis A Revicki, Miriam Kimel, Kathy Beusterien, et al.
Journal of General Internal Medicine
|
May 7, 2008
In-office discussions of migraine: results from the American Migraine Communication Study
Richard B Lipton, Steven R Hahn, Roger K Cady, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Headache
|
April 11, 2012
The development of a survey to measure completeness of response to migraine therapy
Cheryl D Coon, Sheri E Fehnel, Kimberly H Davis, et al.
Headache
|
February 1, 2008
Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines
Merle L Diamond, Roger K Cady, Lian Mao, et al.
Headache
|
October 13, 2009
Expanding access to triptans: assessment of clinical outcome
Roger K Cady, Jerome Goldstein, Stephen Silberstein, et al.
Headache
|
August 16, 2008
Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study
George Apostol, Roger K Cady, Genevieve A Laforet, et al.
Headache
|
November 3, 2010
Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database
Anthony J Rodgers, Carolyn M Hustad, Roger K Cady, et al.
Headache
|
May 6, 2015
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks
Stewart J Tepper, Roger K Cady, Stephen Silberstein, et al.
Headache
|
February 16, 2007
Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study)
Ninan T Mathew, Gary Finlayson, Timothy R Smith, et al.
Headache
|
October 31, 2014
A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study)
Roger K Cady, Peter J McAllister, Egilius L H Spierings, et al.
Headache
|
February 24, 2006
Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment
Dennis A Revicki, Miriam Kimel, Kathy Beusterien, et al.
Journal of General Internal Medicine
|
May 7, 2008
In-office discussions of migraine: results from the American Migraine Communication Study
Richard B Lipton, Steven R Hahn, Roger K Cady, et al.
Page
of 7